Literature DB >> 34631891

Thyroid Transcription Factor-1: Structure, Expression, Function and Its Relationship with Disease.

Lian Guan1,2, Xu Zhao1,2, Lin Tang1,2, Jing Chen1,2, Juanjuan Zhao1,2, Mengmeng Guo1,2, Chao Chen1,2, Ya Zhou3, Lin Xu1,2.   

Abstract

Thyroid transcription factor-1 (TTF-1/NKx2.1) is a member of the NKx2 tissue-specific transcription factor family, which is expressed in thyroid follicle, parathyroid gland, alveolar epithelium, and diencephalon which originated from ectoderm, and participates in the differentiation, development, and functional maintenance of the above organs. Recent studies have shown that the abnormal expression of TTF-1 is closely related to the occurrence of a variety of human diseases and can be used as a potential new target for the diagnosis and treatment of related diseases. In this article, in order to strengthen the systematic understanding of TTF-1 and promote the progress of related research, we reviewed the structure, expression regulation, biological functions of TTF-1, and its role in the occurrence and development of human-related clinical diseases. Meanwhile, we prospect the future research direction of TTF-1, which might ultimately contribute to the understanding of the pathogenesis of related clinical diseases and the development of new prevention and treatment strategies.
Copyright © 2021 Lian Guan et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34631891      PMCID: PMC8494563          DOI: 10.1155/2021/9957209

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  69 in total

1.  TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas.

Authors:  Z Liu; K Yanagisawa; S Griesing; M Iwai; K Kano; N Hotta; T Kajino; M Suzuki; T Takahashi
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

2.  Multiple transcripts encoded by the thyroid-specific enhancer-binding protein (T/EBP)/thyroid-specific transcription factor-1 (TTF-1) gene: evidence of autoregulation.

Authors:  H Oguchi; S Kimura
Journal:  Endocrinology       Date:  1998-04       Impact factor: 4.736

3.  A dominant negative CREB (cAMP response element-binding protein) isoform inhibits thyrocyte growth, thyroid-specific gene expression, differentiation, and function.

Authors:  L Q Nguyen; P Kopp; F Martinson; K Stanfield; S I Roth; J L Jameson
Journal:  Mol Endocrinol       Date:  2000-09

4.  Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung.

Authors:  M T Stahlman; M E Gray; J A Whitsett
Journal:  J Histochem Cytochem       Date:  1996-07       Impact factor: 2.479

5.  A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.

Authors:  Elly S W Ngan; Brian H H Lang; Tingting Liu; Cathy K Y Shum; Man-Ting So; Danny K C Lau; Thomas Y Y Leon; Stacey S Cherny; Sophia Y Tsai; Chung-Yau Lo; Ui-Soon Khoo; Paul K H Tam; Maria-Mercè Garcia-Barceló
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

6.  Characterizing the cancer genome in lung adenocarcinoma.

Authors:  Barbara A Weir; Michele S Woo; Gad Getz; Sven Perner; Li Ding; Rameen Beroukhim; William M Lin; Michael A Province; Aldi Kraja; Laura A Johnson; Kinjal Shah; Mitsuo Sato; Roman K Thomas; Justine A Barletta; Ingrid B Borecki; Stephen Broderick; Andrew C Chang; Derek Y Chiang; Lucian R Chirieac; Jeonghee Cho; Yoshitaka Fujii; Adi F Gazdar; Thomas Giordano; Heidi Greulich; Megan Hanna; Bruce E Johnson; Mark G Kris; Alex Lash; Ling Lin; Neal Lindeman; Elaine R Mardis; John D McPherson; John D Minna; Margaret B Morgan; Mark Nadel; Mark B Orringer; John R Osborne; Brad Ozenberger; Alex H Ramos; James Robinson; Jack A Roth; Valerie Rusch; Hidefumi Sasaki; Frances Shepherd; Carrie Sougnez; Margaret R Spitz; Ming-Sound Tsao; David Twomey; Roel G W Verhaak; George M Weinstock; David A Wheeler; Wendy Winckler; Akihiko Yoshizawa; Soyoung Yu; Maureen F Zakowski; Qunyuan Zhang; David G Beer; Ignacio I Wistuba; Mark A Watson; Levi A Garraway; Marc Ladanyi; William D Travis; William Pao; Mark A Rubin; Stacey B Gabriel; Richard A Gibbs; Harold E Varmus; Richard K Wilson; Eric S Lander; Matthew Meyerson
Journal:  Nature       Date:  2007-11-04       Impact factor: 49.962

7.  Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.

Authors:  Hisaaki Tanaka; Kiyoshi Yanagisawa; Keiko Shinjo; Ayumu Taguchi; Ken Maeno; Shuta Tomida; Yukako Shimada; Hirotaka Osada; Takayuki Kosaka; Hideo Matsubara; Tetsuya Mitsudomi; Yoshitaka Sekido; Mitsune Tanimoto; Yasushi Yatabe; Takashi Takahashi
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

8.  Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene.

Authors:  D Civitareale; M P Castelli; P Falasca; A Saiardi
Journal:  Mol Endocrinol       Date:  1993-12

9.  Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.

Authors:  Valsamo K Anagnostou; Konstantinos N Syrigos; Gerold Bepler; Robert J Homer; David L Rimm
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

10.  Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Asgeir Sigurdsson; Jon T Bergthorsson; Huiling He; Thorarinn Blondal; Frank Geller; Margret Jakobsdottir; Droplaug N Magnusdottir; Sigurborg Matthiasdottir; Simon N Stacey; Oskar B Skarphedinsson; Hafdis Helgadottir; Wei Li; Rebecca Nagy; Esperanza Aguillo; Eduardo Faure; Enrique Prats; Berta Saez; Mariano Martinez; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Kristleifur Kristjansson; Michael L Frigge; Hoskuldur Kristvinsson; Jeffrey R Gulcher; Thorvaldur Jonsson; Thorunn Rafnar; Hannes Hjartarsson; Jose I Mayordomo; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-02-06       Impact factor: 38.330

View more
  2 in total

Review 1.  Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy.

Authors:  Weijie Cao; Haizhou Xing; Yingmei Li; Wenliang Tian; Yongping Song; Zhongxing Jiang; Jifeng Yu
Journal:  Biomark Res       Date:  2022-05-31

Review 2.  Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.

Authors:  María Sánchez-Ares; Soledad Cameselle-García; Ihab Abdulkader-Nallib; Gemma Rodríguez-Carnero; Carolina Beiras-Sarasquete; José Antonio Puñal-Rodríguez; José Manuel Cameselle-Teijeiro
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-28       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.